Sorafenib-mediated suppression of miR-30a-5p, which acts as a transcriptional repressor of CLCF1, results in upregulation of CLCF1 in sorafenib-resistant HCC cells [105]. Here, CLCF1 is linked to hepatocellular carcinoma.